Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cazzola (Rome, Italy). New bronchodilators. Annual Congress 2012 - The promise of new drugs for treating asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: New bronchodilators and inhaled steroids Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences Year: 2011 Novel long-acting bronchodilators Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 Emerging inhaled bronchodilators: an update Source: Eur Respir J 2009; 34: 757 Year: 2009 Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007 Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids Source: Eur Respir J 2016; 48: 558-560 Year: 2016 Cough variant asthma treated with bronchodilators, without inhaled corticosteroids Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 Inhaled corticosteroid combined with long-acting bronchodilator versus long-acting bronchodilator alone for older patients with COPD Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 lnhaled long-acting beta-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults Source: Eur Respir J 2005; 26: Suppl. 49, 124s Year: 2005 The effect of inhaled corticosteroids in combination with long-acting beta2-agonists in elite athletes with asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Long-acting bronchodilators in COPD: where are we now and where are we going? Source: Breathe 2014; 10:110-120 Year: 2014 Bronchodilator therapies for severe asthma Source: Eur Respir Mon 2011; 51: 253-267 Year: 2011 The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016 Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5 Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Low dose inhaled corticosteroids (ICS) and short-acting beta-agonists (SABA) or long-acting beta-agonists (LABA) need in children and adolescents with asthma steps 1 and 2: what is the evidence? Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids Source: Eur Respir J 2002; 19: 182-191 Year: 2002